69 reports

Plaque Psoriasis (Psoriasis Vulgaris)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

100 pages • By Delve Insight

DelveInsight’s, “Plaque Psoriasis (Psoriasis Vulgaris)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Plaque Psoriasis (Psoriasis Vulgaris). A key objective of DelveInsight’s report is to establish the understanding...

1 600 2 000 1 280
Feb 2015

Acne Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

100 pages • By Delve Insight

DelveInsight’s, “Acne Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Acne Vulgaris. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III...

1 600 2 000 1 280
Feb 2015

Chronic Plaque Psoriasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

100 pages • By Delve Insight

DelveInsight’s, “Chronic Plaque Psoriasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Chronic Plaque Psoriasis. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for...

1 600 2 000 1 280
Feb 2015

Onychomycosis (Tinea Unguium)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

100 pages • By Delve Insight

DelveInsight’s, “Onychomycosis (Tinea Unguium)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Onychomycosis (Tinea Unguium). A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers...

1 600 2 000 1 280
Feb 2015

Acute Cutaneous Lupus Erythematosus (ACLE)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

100 pages • By Delve Insight

DelveInsight’s, “Acute Cutaneous Lupus Erythematosus (ACLE)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Acute Cutaneous Lupus Erythematosus (ACLE). A key objective of DelveInsight’s report is to establish the understanding...

1 600 2 000 1 280
Feb 2015

Chronic Plaque Psoriasis - Pipeline Review, H1 2015

109 pages • By Global Markets Direct

Chronic Plaque Psoriasis - Pipeline Review, H1 2015SummaryGlobal Markets Direct’s, ‘Chronic Plaque Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Chronic Plaque Psoriasis’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Chronic Plaque...

1 600 2 000 1 280
Jan 2015

Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2015

80 pages • By Global Markets Direct

Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2015SummaryGlobal Markets Direct’s, ‘Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2015’, provides an overview of the Onychomycosis (Tinea Unguium)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for...

1 600 2 000 1 280
Jan 2015

Global Acne Treatment Market: Trends and Opportunities (2014-2019)

65 pages • By Daedal Research

Scope of the ReportThe report titled “Global Acne Treatment Market: Trends and Opportunities (2014-2019)” provides an insight into the acne market with focus on global prescription drugs. The report assesses the market sizing and growth of the global acne market, the growth of acne market in various regions and the growth and...

640 800 512
Jan 2015

Androgenic Alopecia - Pipeline Review, H2 2014

56 pages • By Global Markets Direct

Androgenic Alopecia - Pipeline Review, H2 2014SummaryGlobal Markets Direct’s, ‘Androgenic Alopecia - Pipeline Review, H2 2014’, provides an overview of the Androgenic Alopecia’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Androgenic Alopecia, complete...

1 600 2 000 1 280
Dec 2014

Onychomycosis (Tinea Unguium) Global Clinical Trials Review, H2, 2014

87 pages • By Global Data

Onychomycosis (Tinea Unguium) Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, “Onychomycosis (Tinea Unguium) Global Clinical Trials Review, H2, 2014" provides data on the Onychomycosis (Tinea Unguium) clinical trial scenario. This report provides elemental information and data relating...

2 000 2 500 1 600
Nov 2014

Global Acne Market 2014-2018

72 pages • By Infiniti Research Limited

About AcneAcne is one of the common dermatological disorders. Acne, or acne vulgaris is an inflammatory disorder of the skin which affects people of almost all age groups. The exact etiology of acne is not fully understood. Although acne does not present a serious threat to health, severe acne can not only be painful, but also affect a...

2 000 2 500 1 600
Nov 2014

Acne Vulgaris-API Insights, 2014

By Delve Insight

SummaryThe active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs...

1 000 1 250 800
Nov 2014

Plaque Psoriasis (Psoriasis Vulgaris)-API Insights, 2014

By Delve Insight

SummaryThe active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs...

1 000 1 250 800
Nov 2014

Plaque Psoriasis (Psoriasis Vulgaris) Global Clinical Trials Review, H2, 2014

132 pages • By Global Data

Plaque Psoriasis (Psoriasis Vulgaris) Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, “Plaque Psoriasis (Psoriasis Vulgaris) Global Clinical Trials Review, H2, 2014" provides data on the Plaque Psoriasis (Psoriasis Vulgaris) clinical trial scenario. This report provides elemental information...

2 000 2 500 1 600
Oct 2014

Chronic Plaque Psoriasis - Pipeline Review, H2 2014

100 pages • By Global Markets Direct

Chronic Plaque Psoriasis - Pipeline Review, H2 2014SummaryGlobal Markets Direct’s, ‘Chronic Plaque Psoriasis - Pipeline Review, H2 2014’, provides an overview of the Chronic Plaque Psoriasis’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Chronic Plaque...

1 600 2 000 1 280
Oct 2014

Cutaneous Lupus Erythematosus Global Clinical Trials Review, H2, 2014

67 pages • By Global Data

Cutaneous Lupus Erythematosus Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, “Cutaneous Lupus Erythematosus Global Clinical Trials Review, H2, 2014" provides data on the Cutaneous Lupus Erythematosus clinical trial scenario. This report provides elemental information and data relating...

2 000 2 500 1 600
Oct 2014

Wounds - Pipeline Review, H2 2014

246 pages • By Global Markets Direct

Wounds - Pipeline Review, H2 2014SummaryGlobal Markets Direct’s, ‘Wounds - Pipeline Review, H2 2014’, provides an overview of the Wounds’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Wounds, complete with comparative analysis at various stages, therapeutics...

1 600 2 000 1 280
Oct 2014

Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H2, 2014

61 pages • By Global Data

Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, “Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H2, 2014" provides data on the Chronic Cutaneous...

2 000 2 500 1 600
Oct 2014

Contact Dermatitis - Pipeline Review, H2 2014

38 pages • By Global Markets Direct

Contact Dermatitis - Pipeline Review, H2 2014SummaryGlobal Markets Direct’s, ‘Contact Dermatitis - Pipeline Review, H2 2014’, provides an overview of the Contact Dermatitis’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Contact Dermatitis, complete with...

1 600 2 000 1 280
Oct 2014

Acne Vulgaris - Pipeline Review, H2 2014, Global Markets Direct

147 pages • By Global Markets Direct

Acne Vulgaris - Pipeline Review, H2 2014SummaryGlobal Markets Direct’s, ‘Acne Vulgaris - Pipeline Review, H2 2014’, provides an overview of the Acne Vulgaris’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Acne Vulgaris, complete with comparative analysis...

1 600 2 000 1 280
Sep 2014

Diabetic Foot Ulcers - Pipeline Review, H2 2014

129 pages • By Global Markets Direct

Diabetic Foot Ulcers - Pipeline Review, H2 2014SummaryGlobal Markets Direct’s, ‘Diabetic Foot Ulcers - Pipeline Review, H2 2014’, provides an overview of the Diabetic Foot Ulcers’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Diabetic Foot Ulcers, complete...

1 600 2 000 1 280
Sep 2014

Epidermolysis Bullosa - Pipeline Review, H2 2014

59 pages • By Global Markets Direct

Epidermolysis Bullosa - Pipeline Review, H2 2014SummaryGlobal Markets Direct’s, ‘Epidermolysis Bullosa - Pipeline Review, H2 2014’, provides an overview of the Epidermolysis Bullosa’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Epidermolysis Bullosa,...

1 600 2 000 1 280
Sep 2014

Eczema - Pipeline Review, H2 2014

45 pages • By Global Markets Direct

Eczema - Pipeline Review, H2 2014SummaryGlobal Markets Direct’s, ‘Eczema - Pipeline Review, H2 2014’, provides an overview of the Eczema’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Eczema, complete with comparative analysis at various stages, therapeutics...

1 600 2 000 1 280
Sep 2014

Alopecia - Pipeline Review, H2 2014

78 pages • By Global Markets Direct

Alopecia - Pipeline Review, H2 2014SummaryGlobal Markets Direct’s, ‘Alopecia - Pipeline Review, H2 2014’, provides an overview of the Alopecia’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Alopecia, complete with comparative analysis at various stages,...

1 600 2 000 1 280
Aug 2014

Atopic Dermatitis - Pipeline Review, H2 2014

281 pages • By Global Markets Direct

Atopic Dermatitis - Pipeline Review, H2 2014SummaryGlobal Markets Direct’s, ‘Atopic Dermatitis - Pipeline Review, H2 2014’, provides an overview of the Atopic Dermatitis’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Atopic Dermatitis, complete with comparative...

1 600 2 000 1 280
Aug 2014

Rosacea - Pipeline Review, H2 2014

106 pages • By Global Markets Direct

Rosacea - Pipeline Review, H2 2014SummaryGlobal Markets Direct’s, ‘Rosacea - Pipeline Review, H2 2014’, provides an overview of the Rosacea’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Rosacea, complete with comparative analysis at various stages, therapeutics...

1 600 2 000 1 280
Aug 2014

Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2014

87 pages • By Global Markets Direct

Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2014SummaryGlobal Markets Direct’s, ‘Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2014’, provides an overview of the Onychomycosis (Tinea Unguium)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for...

1 600 2 000 1 280
Aug 2014

Actinic (Solar) Keratosis - Pipeline Review, H2 2014

92 pages • By Global Markets Direct

Actinic (Solar) Keratosis - Pipeline Review, H2 2014SummaryGlobal Markets Direct’s, ‘Actinic (Solar) Keratosis - Pipeline Review, H2 2014’, provides an overview of the Actinic (Solar) Keratosis’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Actinic (Solar)...

1 600 2 000 1 280
Aug 2014

Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE)-Pipeline Insights, 2014

By Delve Insight

SUMMARYDelveInsight’s,“ Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Chronic...

1 000 1 250 800
Aug 2014

Venous Leg Ulcers-Pipeline Insights, 2014

By Delve Insight

SUMMARYDelveInsight’s,“ Venous Leg Ulcers-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Venous Leg Ulcers. This report provides information on the therapeutic...

1 000 1 250 800
Aug 2014